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Hospital pharmacists prepare morphine oral solution extemporaneously in Taiwan
because of the unavailability of commercial products. According to the United States
Pharmacopeia <795>, extemporaneous oral solution has an expiration of 14 days if there is
no stability test data. However, outpatients usually need 4-week medications. The purpose
of this study was to determine the beyond-use date of extemporaneous morphine hy-
drochloride (HCl) oral solution. Extemporaneous 0.1% morphine HCl oral solutions were
prepared in an International Organization for Standardization (ISO) Class 8 compounding
room, and bottled in 500-mL high-density polyethylene (HDPE) bottles with polypropylene
caps. Twelve bottles were divided into 2 groups (sealed or opened daily) and stored under
refrigeration or at room temperature to determine the chemical and microbial stabilities.
Stability tests of the “sealed” group were performed after 4 weeks, while for the group in
which the bottles were shaken and opened twice daily, stability tests were performed
weekly. Chemical stability was determined by high performance liquid chromatography
and pH, and microbial stability was determined by microbial limit tests according to
pharmacopeias. In both groups, all the morphine HCl oral solutions retained more than
90% of the original concentration after 4 weeks, irrespective of whether they were stored at
room temperature or in the refrigerator. The pH values were maintained at around 5 during
the 4-week study period. All the refrigerated solutions passed the microbial limit tests
within 4 weeks, regardless of whether they were sealed or opened twice daily. All the
solutions stored at room temperature retained their microbial stability in the 1st week.
However, mold and yeast counts exceeded the limits during the 2nd week in the “opened
daily” group. Extemporaneous 0.1% morphine HCl oral solutions prepared in an ISO Class 8
clean room have a beyond-use date of 4 weeks in HDPE bottles when refrigerated. The
beyond-use date decreased to 1 week when stored at room temperature. Extrapolation of
this result may be limited by different compounding environments, containers or
formulations.
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j o u r n a l o f f o o d and d ru g an a l y s i s 2 1 ( 2 0 1 3 ) 1 4 2e1 4 6 1431. Introduction average temperature and humidity in the compounding roomMorphine is a narcotic analgesic widely used in pain control
for trauma and cancer patients. However, the dosage varies
according to severity of pain and adverse effects [1,2]. In
Taiwan, only 5-mg and 10-mg immediate-release morphine
tablets are available for acute pain control. Compared to im-
mediate- and controlled-release morphine tablets, morphine
oral solution has an earlier onset, is easier to take and more
convenient for dose titration. Morphine solution is preferred
in cancer patients who require tube feeding or have diffi-
culties in swallowing. In our hospital, morphine solution ac-
counts for 37%e40% ofmorphine prescriptions. Many hospital
pharmacists have to prepare morphine oral solution extem-
poraneously because it is not available commercially. To
ensure the quality of the drug, extemporaneously com-
pounded drugs must be stored properly and have an appro-
priate beyond-use date (BUD) [3].
According to the United States Pharmacopeia (USP) <795>,
an extemporaneous oral solution has a BUD of 14 days if there
is no stability test data [3]. As some outpatients require 4-week
medications, a BUD of 14 days cannot meet clinical needs. In
addition, nursing stations usually do not have a refrigerator
exclusively for Schedule I drugs like morphine. According to
the literature, extemporaneous 0.1% morphine sulfate solu-
tion prepared from injection is stable for 91 days [4]. However,
it is necessary to confirm if this applies to extemporaneous
morphine hydrochloride (morphine HCl) oral solution pre-
pared from raw material. The purpose of this study was to
determine the storage conditions and BUD of morphine HCl
oral solution through stability tests.2. Methods
2.1. Sample preparation, reagents, chemicals and study
design
The study samples (morphine oral solutions) were prepared
from morphine HCl raw material obtained from the Taiwan
Food and Drug Administration. It was dissolved in sterile
water for irrigation to make a 1% morphine HCl solution, and
further diluted with sterile water for irrigation to 0.1%. The
final solution was placed in 500-mL high-density polyethylene
(HDPE) bottles with polypropylene caps. All the preparations
were performed in an International Organization for Stan-
dardization (ISO) 146441-1 Class 8 compounding room. TheTable 1 e Intra-day and inter-day repeatabilities of morphine
Morphine HCl
concentration
(mg/mL)
Day 1 Day
Mean peak area RSD (%) Mean peak are
0.4389 2381.5 0.18 2383.1
0.5486 2937.7 0.16 2944.1
0.8229 4409.7 0.21 4412.6
RSD¼ relative standard deviation; n¼ 9.were 21.6 1.4 C and 64.6 7.1%, respectively.
Twelve bottles of 0.1%morphine HCl solution were divided
into 2 groups (sealed or opened daily) to determine the
chemical andmicrobial stabilities. Six bottleswere sealed after
preparation. Three of them were stored at room temperature,
and another three were refrigerated. Stability tests were per-
formed after 4 weeks. Another 6 bottles were shaken and
opened twice daily in a laboratory that was air-conditioned
only in the daytime. Three of them were refrigerated, and
another threewere stored at room temperature in a laboratory
where the humidity was 52%e65%, and temperature was less
than 25 C in the daytime and 25e28 C in the evening and
night. Stability tests were performed weekly on days 7, 14, 21
and 28.
Stability tests of pharmaceuticals usually include chemi-
cal, physical, microbial, therapeutic and toxicological stabil-
ities [3,5]. As morphine solution may oxidize and discolor [6,7]
and our product is preservative-free, this study focused on
chemical and microbial stabilities.
High-performance liquid chromatography (HPLC)-grade
solvents, such as methanol (mobile phase) and triethylamine
(an alkylating agent of themobile phase) were purchased from
Merck KGaA (Darmstadt, Germany). Ammonium acetate
and acetic acid (glacial), which are pH buffer agents of the
mobile phase, were also purchased fromMerck KGaA. Sodium
1-heptanesulfonate, a surfactant of the mobile phase, was
from Fluka (Steinheim, Germany).2.2. Equipment and analysis
All the analyses were repeated thrice. Chemical stability was
determined through morphine assay by HPLC according to
pharmacopeia and literature [3,8,9]. The linearity and
repeatability of the morphine concentration analysis method
used has been previously validated [10].
A sonicator (T710DH; Elma-Hans Schmidbauer GmbH & Co
KG, Singen, Germany) was used for assay sample preparation.
A HPLC system (Agilent Technologies Inc., Palo Alto, CA,
USA) consisting of a pump (G1311A), degasser (G1322A),
photodiode array (PDA)-detector (G1315B) and autosampler
(G1329A) was used to analyze the samples. The analytical
column was a LiChroCART 250-4 Purospher STAR RP-18e C18
column (250  4 mm, particle size 5 mm, from Merck, Inc.,
Darmstadt, Germany). Assay was performed according to the
stability-indicating HPLC method for morphine [7]. Morphine
was detected by UV absorption at 284 nm at a retentionHCl assay.
2 Day 3 RSD (%) of
Day 1eDay 3
a RSD (%) Mean peak area RSD (%)
0.14 2382.4 0.10 0.14
0.13 2944.1 0.13 0.17
0.09 4415.1 0.16 0.16
Table 2 e Recovery of morphine HCl in aqueous solution.
Theoretical
concentration
(mg/mL)
Assay
results
(mg/mL)
RSD
(%)
Recovery
(%)
Mean SD
(%)
0.4389 0.4385 0.14 99.90 99.35 0.44
0.5486 0.5427 0.17 98.92
0.8229 0.8166 0.16 99.23
RSD¼ relative standard deviation.
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mixture of aqueous solution (containing 1% ammonium ace-
tate, 1% acetic acid, 0.8% triethylamine and 0.017% sodium
1-heptanesulfonate) and methanol (85:15).
A pH meter (PHM210; Radiometer, Lyon, France) was used
to determine the pH of the solution.
Microbial stability was determined by microbial limit tests
according to USP <62>, <1111> and the Chinese Pharmaco-
peia (ChP) [3,9], which included Escherichia coli, molds, yeasts
and total aerobes.3. Results and discussion
3.1. Physicochemical stability
The chemical stability of morphine HCl oral solutions was
assayed by HPLC according to the methods in pharmacopeias
[3,9]. Linear response of the morphine HCl peak areas in
the range of 0.215e0.860 mg/mL was demonstrated by aFig. 1 e Representative chromatograms of 1.0 mg/mL morphine
for 28 days at room temperature; (D) stored for 28 days in the rcorrelation coefficient greater than 0.999. The inter-day
and intra-day repeatabilities of morphine HCl are shown in
Table 1. All the inter-day and intra-day relative standard de-
viations (RSD) were less than 0.5%. Recovery was in the range
of 99.35 0.44% when 0.4389 mg/mL, 0.5486 mg/mL and
0.8229 mg/mL morphine HCl were analyzed (Table 2). In addi-
tion, the method was already proven [1,2] to be a stability-
indicating HPLC method [10]. The results of the representa-
tive chromatograms of the standard of morphine HCl in water
and samples of morphine HCl oral solutions are shown in
Fig. 1. The retention time was 7.5 minutes in the standard and
samples. All the morphine HCl oral solutions, whether sealed
or opened twice daily, retainedmore than 95% (97.1e99.6%) of
the original concentration after 28 days irrespective of storage
temperature (Fig. 2, Table 3). ThepHvaluesweremaintainedat
around 5 (5.34e5.66) during the 4-week study period under
different storage conditions (Fig. 2). The color and clarity of the
morphine solutions remained unchanged during the study
period. Therefore, the solutions were chemically stable for at
least 28 days whether sealed or open, refrigerated or stored at
room temperature.
It has been reported that themajor degradation products of
morphine in aqueous solution are pseudomorphine and
morphine-N-oxide due to its oxidative reaction [6,11,12]. More
degradation is observedwhenmorphine solution is in a higher
pH of 2e7 or in an oxygen-rich environment [6,13e15]. On the
contrary, light and temperature have less impact on stability,
which is consistent with our findings. In our study, the
morphine HCl oral solutions were stable at both room tem-
perature and in the refrigerator when they were in an amiable
weakly acidic condition (pH 5.3e5.7).HCl in water: (A) standard; (B) sampled at Day 0; (C) stored
efrigerator. Morphine has a retention time of 7.5 minutes.
Fig. 2 e Chemical stability of extemporaneous morphine HCl solution. The bars and lines represent the morphine content
compared to that on Day 0 and pH values, respectively, in different conditions of morphine HCl oral solution. The morphine
content on Day 0 was considered to be 100%.
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color has been observedwhen degradation products are found
in morphine solution [6,12]. In our study, the samples of
morphine HCl oral solutions remained clear during the 4-
week experiment under all the storage conditions.
3.2. Microbial stability
According to microbial limit tests of USP <1111>, the total
aerobic microbial count should not exceed 100 cfu/mL, total
combined yeast/mold count should not exceed 10 cfu/mL, and
no E. coli should be detected [3]. All the refrigerated solutions
passed these microbial limit tests in the 4-week study period,
regardless of whether they were sealed or opened twice daily
(Table 4).
To prevent contamination from microorganisms, it has
been suggested that preservatives be added to the extem-
poraneous aqueous solution [14,16e18]. If the addition of
preservatives to the extemporaneous aqueous solution is
contraindicated, the BUD can be set at 14 days when theTable 3 e Chemical stability of extemporaneous morphine HC
Group Opened Open
Storage
temperature
Room temperature Refriger
Mea
Day
0 0.953 0.020 0.943 0
7 0.941 0.002 0.949 0
14 0.939 0.003 0.949 0
21 0.938 0.004 0.948 0
28 0.925 0.006 0.932 0
NA¼not available.solutions are stored under refrigeration [3]. Our study found
that morphine HCl oral solution prepared with sterile water
without the addition of any preservative can retain their
microbial stability for 28 days when they are refrigerated.
Microbial growth is unlikely in the solution under refriger-
ation whether the bottles are opened daily or not. However,
when stored at room temperature, all the solutions in both
groups retained their microbial stability in the 1st week
only. The total combined yeast/mold count exceeded the
limit (>10 cfu/mL) during the 2nd week in the “opened daily”
group and during the 4th week in the sealed group. Daily
opening influenced microbial stability when the solutions
were stored at room temperature. According to our results,
morphine oral solution shows both chemical and microbial
stability at room temperature for at least 7 days. This pro-
vides evidence to allow morphine oral solution to be stored
in a locked medication cart or space at room temperature
and solves the problem of accommodating the bulky bottles
in the limited refrigerator space that is generally found in
nursing stations.l solution.
ed Sealed Sealed
ated Room temperature Refrigerated
n concentration (mg/mL)
.010 0.938 0.012 0.945 0.008
.011 NA NA
.006 NA NA
.012 NA NA
.008 0.934 0.017 0.930 0.006
Table 4 e Microbial limit tests of extemporaneous 0.1% morphine HCl oral solution.a
Day Room temperature Refrigerated
Total aerobes Yeasts and
molds
E. coli Total
aerobes
Yeasts and
molds
E. coli
Opened twice daily
0 Pass Pass Pass Pass Pass Pass
7 Pass Pass Pass Pass Pass Pass
14 Pass Fail Pass Pass Pass Pass
21 Pass Fail Pass Pass Pass Pass
28 Pass Fail Pass Pass Pass Pass
Sealed and stored
0 Pass Pass Pass Pass Pass Pass
28 Pass Fail Pass Pass Pass Pass
cfu¼ colony forming unit.
a According to USP <1111>, aerobes should not exceed 100 cfu/mL, yeasts and molds should not exceed 10 cfu/mL, and no E. coli should be
detected.
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According to our chemical and microbial stability tests,
extemporaneous 0.1%morphine HCl oral solutions prepared in
an ISOClass 8 compounding roomwith anaverage temperature
of 21.6 C and humidity of 64.6%, and bottled in HDPE bottles
with polypropylene caps, has a BUD of 4 weeks when refriger-
ated. When the bottle was opened twice daily in a room,
mimicking patients’ homes that tend to be air-conditioned for
only 9e10 hours a day, the BUD decreased to 1 week when
storedat roomtemperaturebecauseofmicrobial instability.We
therefore recommend that patients store the solution in the
refrigerator. However, at a nursing station in a hospital where
there is 24-hourair-conditioning, themorphine solutionmaybe
locked in themedication cart for 1 week. Microbial stability is a
major concern in determining storage condition and the BUD
for an extemporaneous oral aqueous solution. Extrapolation of
this result may be limited by different compounding environ-
ments, containers or formulations.Acknowledgments
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